TLDR Microsoft director John W. Stanton bought 5,000 shares of MSFT at $397.35 per share, totaling $1.98 million on February 18, 2026. Following the purchase, StantonTLDR Microsoft director John W. Stanton bought 5,000 shares of MSFT at $397.35 per share, totaling $1.98 million on February 18, 2026. Following the purchase, Stanton

Microsoft (MSFT) Stock Down 17% YTD as Director Makes $1.98M Purchase

2026/02/19 17:23
3 min read

TLDR

  • Microsoft director John W. Stanton bought 5,000 shares of MSFT at $397.35 per share, totaling $1.98 million on February 18, 2026.
  • Following the purchase, Stanton directly owns 83,905 shares, plus 3,622 shares held indirectly through a family trust.
  • Despite the buy, overall insider sentiment for MSFT is rated Negative by TipRanks, with $4.5 million in insider sells over the past three months.
  • MSFT stock is down more than 17% year-to-date.
  • Wall Street analysts remain bullish, with a Strong Buy consensus and an average price target of $593.38 — implying 48.5% upside.

Microsoft director John W. Stanton picked up 5,000 shares of MSFT on February 18, 2026, at $397.35 per share, for a total of $1.98 million.


MSFT Stock Card
Microsoft Corporation, MSFT

The purchase brings Stanton’s direct ownership to 83,905 shares. He also holds an additional 3,622 shares indirectly through a family trust.

Insider purchases like this tend to catch the eye of retail investors. When a director reaches into their own pocket to buy at market prices, it can be read as a vote of confidence in the company’s direction.

But one buy doesn’t tell the whole story.

MSFT is down more than 17% year-to-date, making Stanton’s purchase a buy into a declining stock. Whether that’s conviction or just opportunistic dip-buying is a matter of perspective.

One Buy vs. a Pattern of Selling

Insider selling doesn’t automatically mean trouble is coming. Executives and directors sell shares for all kinds of reasons — diversification, taxes, personal expenses.

But when selling outpaces buying by a wide margin over multiple months, it can suggest that those closest to the company aren’t rushing to add exposure at current prices.

Stanton’s $1.98 million purchase stands out as the most meaningful buy in recent months. Whether it marks a turning point in insider activity remains to be seen.

Wall Street Still Bullish

Despite the mixed insider picture, analyst sentiment on MSFT is firmly positive.

TipRanks shows a Strong Buy consensus rating based on the last three months of analyst activity — 32 Buy ratings against just four Holds. No analyst has a Sell on the stock.

The average price target sits at $593.38, which would represent a 48.5% gain from current levels.

Microsoft has continued to benefit from strong cloud demand and momentum around its AI investments. The company recently announced plans to invest $50 billion in AI infrastructure across developing nations in the Global South, an announcement made at the AI summit in New Delhi.

That kind of long-term capital commitment may help explain why analysts remain optimistic even as the stock has struggled in 2026.

MSFT closed at approximately $397 on February 18, 2026, the same day Stanton executed his purchase.

The post Microsoft (MSFT) Stock Down 17% YTD as Director Makes $1.98M Purchase appeared first on CoinCentral.

Market Opportunity
Ucan fix life in1day Logo
Ucan fix life in1day Price(1)
$0.0005453
$0.0005453$0.0005453
-1.81%
USD
Ucan fix life in1day (1) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.